Cargando...
Interleukin-17 Could Promote Breast Cancer Progression at Several Stages of the Disease
Metastatic disease accounts for more than 90% of deaths from breast cancer. Yet the factors that trigger metastasis, often years after primary tumor removal, are not understood well. Recently the proinflammatory cytokine interleukin- (IL-) 17 family has been associated with poor prognosis in breast...
Gardado en:
| Publicado en: | Mediators Inflamm |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Hindawi Publishing Corporation
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4691460/ https://ncbi.nlm.nih.gov/pubmed/26783383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/804347 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|